Veteran healthcare and consumer technology operator turned investor with experience scaling growth-stage companies and advising boards on commercial strategy and go-to-market execution. Jane Bortnem has led marketing and product functions at venture-backed startups and served as an executive-in-residence and angel investor, focusing on customer acquisition, retention economics and category expansion. Market relevance centers on growth equity and early-stage rounds where operational playbooks and customer-driven scaling drive valuation upside.
Veteran healthcare and consumer technology operator turned investor with experience scaling growth-stage companies and advising boards on commercial strategy and go-to-market execution. Jane Bortnem has led marketing and product functions at venture-backed startups and served as an executive-in-residence and angel investor, focusing on customer acquisition, retention economics and category expansion. Market relevance centers on growth equity and early-stage rounds where operational playbooks and customer-driven scaling drive valuation upside.
Focuses on growth-stage healthcare and consumer technology companies where operator-led capital accelerates customer acquisition and retention-driven revenue. Prefers early growth equity and seed rounds, underwriting opportunities through unit-economics, payback period and category expansion potential. Deploys smaller, active checks coupled with board or advisor roles to drive go-to-market execution, product-market fit and scalable acquisition channels. Time horizon is multi-year, value creation through commercial scaling and disciplined follow-on allocation to protect ownership and upside.
Focuses on growth-stage healthcare and consumer technology companies where operator-led capital accelerates customer acquisition and retention-driven revenue. Prefers early growth equity and seed rounds, underwriting opportunities through unit-economics, payback period and category expansion potential. Deploys smaller, active checks coupled with board or advisor roles to drive go-to-market execution, product-market fit and scalable acquisition channels. Time horizon is multi-year, value creation through commercial scaling and disciplined follow-on allocation to protect ownership and upside.
| Trades 3211 | Longs Won 2282/3211 71% | Profit Factor 24.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $302,652.52 |
| Average Win $53,867.4 | Best Trade (Jul 14) $6.83M | Sharpe Ratio -11.24 |
| Average Loss -$5,501.34 | Worst Trade (Jul 10) -$2.75M | Z-Score 14.47 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 6d | Expectancy $36,690.96 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 90,909 | 81,818 | 72,727 | 63,636 | 54,545 | 45,455 | 36,364 | 27,273 | 18,182 | 9,091 |